We are live on
!
Find out more
BWFA
Baltimore-Washington Financial Advisors Portfolio holdings
AUM
$2.32B
1-Year Est. Return
16.8%
This Fund
S&P 500
This Quarter
Est. Return
+3.75%
1 Year Est. Return
+16.8%
3 Year Est. Return
+70.75%
5 Year Est. Return
+74.93%
10 Year Est. Return
+302.42%
AUM
$416M
AUM Growth
+$23.3M
(+5.9%)
Cap. Flow
+$11.2M
Cap. Flow
% of AUM
2.68%
Top 10 Holdings %
Top 10 Hldgs %
25.59%
Holding
75
New
5
Increased
52
Reduced
12
Closed
5
Top Buys
| 1 |
Starbucks
SBUX
|
+$5.23M |
| 2 |
Alibaba
BABA
|
+$4.4M |
| 3 |
Under Armour Class C
UA
|
+$3.3M |
| 4 |
Box
BOX
|
+$3M |
| 5 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$1.7M |
Top Sells
| 1 |
AGN.PRA
Allergan plc
AGN.PRA
|
+$5.36M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$4.91M |
| 3 |
Qualcomm
QCOM
|
+$3.2M |
| 4 |
Gentex
GNTX
|
+$2.89M |
| 5 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$2.55M |
Sector Composition
| 1 | Financials | 14.91% |
| 2 | Healthcare | 9.83% |
| 3 | Technology | 9.43% |
| 4 | Consumer Discretionary | 7.92% |
| 5 | Communication Services | 6.21% |
Similar funds
DIA
FBIL
CM
NDSIB
ABI
MFAM
ST
EPM
Baltimore-Washington Financial Advisors's Q2 2017 Portfolio in Review
As of Q2 2017, Baltimore-Washington Financial Advisors held 75 positions worth $416M, up 5.9% from $393M the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Baltimore-Washington Financial Advisors's Q2 2017 filing shows 5 new, 52 increased, 12 reduced and 5 closed positions. Its largest new stake was Alibaba: 35,646 shares worth $5.02M. The largest sale was Allergan plc, an estimated $5.36M.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 15% a quarter earlier, followed by Healthcare and Technology.
- Baltimore-Washington Financial Advisors's largest Q2 2017 buy was Alibaba: 35,646 shares worth $5.02M.
- Baltimore-Washington Financial Advisors added most to Starbucks in Q2 2017, an estimated $5.23M increase.
- Baltimore-Washington Financial Advisors's biggest Q2 2017 reduction was Gentex, cutting an estimated $2.89M.
- Baltimore-Washington Financial Advisors fully exited Allergan plc in Q2 2017, selling an estimated $5.36M.
- Baltimore-Washington Financial Advisors's ten largest holdings make up 26% of its $416M portfolio in Q2 2017.
- Baltimore-Washington Financial Advisors opened 5 new positions and closed 5 in Q2 2017.
- Baltimore-Washington Financial Advisors's portfolio value rose 5.9% quarter-over-quarter to $416M.
Based on Baltimore-Washington Financial Advisors's 13F filing for Q2 2017, filed 17 Jul 2017.